CS Medica is a Danish MedTech company, dedicated to pharmaceutical research, development, manufacturing, and worldwide commercialization. The company blends science and nature to improve patients' lives with cannabinoid therapies for pain relief and addressing autoimmune and stress-related symptoms. Globally, CS Medica offers over-the-counter (OTC) CBD treatments, including patented medical products, MHRA, and MDR-registered items, marketed under the brand CANNASEN® or with its own labeling.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Lone Henriksen | 37,54 | 37,54 | 2023-03-01 |
| Gitte Henriksen | 32,88 | 32,88 | 2023-03-01 |
| Finn-Ove Henriksen and Nina Henriksen | 3,34 | 3,34 | 2022-06-30 |
| Diaz Capital Invest AB | 3,16 | 3,16 | 2022-08-24 |
| Ylber Rexhepi | 2,32 | 2,32 | 2022-06-30 |
| Tonoy Sayeed | 1,46 | 1,46 | 2022-06-30 |
| Michael Kaa Andersen | 1,18 | 1,18 | 2022-06-30 |
| Tobias Ryde | 1,10 | 1,10 | 2022-06-30 |
| Kent Eklund | 1,03 | 1,03 | 2022-06-30 |
| Taulant Bara | 1,03 | 1,03 | 2022-06-30 |
2024-02-24 Bokslutskommuniké 2023
2024-02-29 Årsstämma 2023
2024-05-17 Delårsrapport 2024-Q1
2024-08-16 Delårsrapport 2024-Q2
2024-11-13 Delårsrapport 2024-Q3
2025-02-14 Bokslutskommuniké 2024